| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.43B | +27.7% |
| Cost of Revenue | $687.0M | +33.3% |
| Gross Profit | $2.74B | +26.3% |
| R&D Expense | $1.55B | +34.3% |
| SG&A Expense | $279.7M | +36.3% |
| Operating Income | -$44.4M | -181.7% |
| Pre-tax Income | $127.0M | -37.7% |
| Income Tax | $19.3M | -4.5% |
| Net Income | $107.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $401.3M | -67.8% |
| Accounts Receivable | $741.3M | +23.8% |
| Current Assets | $5.38B | +9.6% |
| Total Assets | $6.64B | +14.8% |
| Current Liabilities | $1.59B | -14.6% |
| Total Liabilities | $2.91B | -5.2% |
| Stockholders' Equity | $3.73B | +37.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.05B | +20.6% |
| Capital Expenditures | $49.6M | +42.8% |
| Investing Cash Flow | -$1.33B | -81.1% |
| Financing Cash Flow | -$572.5M | -172.7% |
| Free Cash Flow | $1.00B | +19.7% |
| -41.4% |
| EPS (Basic) | $0.31 | -43.6% |
| EPS (Diluted) | $0.31 | -40.4% |